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a b s t r a c t
Inﬂuenza is a contagious disease caught by humans caused by viruses belonging to the family
Orthomyxoviridae. Each year, the inﬂuenza virus infects millions of people and kills hundreds of thousands
of them. Traditional diagnostic methods, such as virus propagation and isolation, antigen capture
immunoassays and molecular methods are not sufﬁcient for the detection of the inﬂuenza virus.
Development of a valid diagnostic assay for quick detection (in less than an hour) of the virus, with high
sensitivity, is a challenge for researchers all over the world.
Here we present a new, universal immunosensor for detection of the inﬂuenza A virus. By using
electrochemical impedance spectroscopy (EIS) and direct attachment of antibodies to the gold electrode
the assay allows detection of the pathogenwith sensitivity similar to molecular methods in relatively short
time. Application of universal anti-M1 antibodies allows detection of all serotypes of inﬂuenza A virus.
The simple design of the sensor facilitates miniaturization of the device and its implementation for
routine diagnostics during ﬁrst contact with the patient, before applying a proper treatment.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Fast, efﬁcient, effective, and low-cost detection of pathogens is
a challenge for scientists all over the world. Considering the
spreading (infection) rate of the inﬂuenza virus during the pan-
demic of 2009 (WHO Website, 2013), it is clear that we need to
develop an effective system for diagnosing the inﬂuenza virus at
the early stages of infection, when the titer of virus in the throat
is low.
During three pandemics in the 20th century, inﬂuenza virus
(family Orthomyxoviridae) killed an estimated 100 million people.
Each year the virus infects around 1 billion people and causes
250,000 deaths. High variability of the virus and its easy spread
make it one of the world’s most dangerous pathogens (de Jong and
Hien, 2006; WHO Website, 2013).
Standard diagnostic methods for detection of the inﬂuenza virus
seem to be insufﬁcient. The traditional methods are based on virus
isolation from tissue cultures (MDCK, Vero) or embryonating
chicken eggs. This effective and sensitive technique requires several
days of analysis involving labor intensive and time-consuming
procedures (Storch, 2000). There are ELISA tests for detection of
virus antigens in the infected organism (He et al., 2007). However,
this method is relatively time-consuming and multistage which
makes it signiﬁcantly more difﬁcult to perform. Moreover, ELISA
provides relatively low sensitivity and may produce false negative
results.
In order to provide maximum sensitivity and speciﬁcity of the
method while maintaining a short time of analysis (a few hours),
currently, the most frequently used methods are based on detec-
tion of the virus genetic material. Molecular methods based on
PCR, RT‐PCR, and Real‐time PCR are more speciﬁc, more sensitive,
and consume less time, compared with traditional methods.
However, a big disadvantage of these methods is the necessity to
isolate the genetic material and to take special care not to
contaminate the sample. Moreover, these methods require the
use of equipment which is not available in outpatient clinics, but
only in diagnostic or scientiﬁc laboratories.
There are several bedside tests which allow a relatively quick (up to
30 min) detection of viral antigens. Unfortunately, these tests provide
low sensitivity and often produce false negative results, especially
during later stages of the disease development. Low sensitivity is the
main reason why these tests are seldom used in routine diagnostics of
inﬂuenza virus (Storch, 2003; Woolcock and Cardona, 2005).
State of the art diagnostic methods combine elements of
biology, chemistry, engineering, and electrochemistry. Methods
based on the most modern technology allow signiﬁcant reduction
of analysis time, while maintaining high sensitivity and speciﬁcity.
A few modern biosensors are known, whose operation is based
on quartz crystal oscillation (Hewa et al., 2009; Li et al., 2011),
refraction changes (Xu et al., 2007), interferometry (Farris et al.,
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2010) carbon nanotubes (Lee et al., 2011), imaging ellipsometry (Qi
et al., 2010) or surface plasmon resonance (Park et al., 2012; Su et
al., 2012). However, these methods require application of highly
sophisticated equipment, and are often difﬁcult to perform,
analyze, and interpret. Moreover, to date, no simple and universal
sensor was developed that would be able to detect all types of the
inﬂuenza A virus.
In this paper we present a new, universal immunosensor for
detection of inﬂuenza virus in swabs from the human throat. The
biosensor is based on impedance electrochemical spectroscopy
and its design involves direct attachment of antibodies to the
electrode.
The antigen used for detection by the developed sensor is the
most conserved and popular structural protein in the virion (M1).
This approach allows quick detection of all types of the inﬂuenza A
virus with a sensitivity comparable to molecular methods.
2. Materials and methods
2.1. Viruses propagation
Avian inﬂuenza A/ostrich/Denmark/96-72420/96 (H5N2),
A/GraylagGoose/Poland/MW74/10 (H5N2) and A/Afri.Star./Eng-Q/
938/79 (H7N1) (kindly provided by Z. Minta and K. Smietanka,
Department of Poultry Diseases, National Veterinary Research
Institute, Pulawy, Poland) and human inﬂuenza A viruses (pan-
demic H1N1 strains) from the collection of the Department of
Recombinant Vaccines, University of Gdansk, Poland were propa-
gated in Madin-Darby canine kidney cells (MDCK) cultured at
37 1C under 5% CO2 in Dulbecco’s Modiﬁed Eagle’s Medium (D-
MEM) (Sigma-Aldrich), supplemented with 2 mM L-glutamine,
0.2% bovine serum albumin, 25 mM HEPES buffer, 100 U/ml of
penicillin, 100 mg/ml of streptomycin in the presence of 2 mg/ml
TPCK (L-1-Tosylamide-2-phenylethyl chloromethyl ketone) – tryp-
sin (Sigma-Aldrich). Viral stocks were stored at 70 1C and
titrated by plaque assay before use.
2.2. Production of recombinant M1 in the bacterial expression
system
The M1 gene of inﬂuenza A virus A/England/195/2009 (H1N1)
was PCR ampliﬁed using plasmid DNA (pPol-M1) as a template
and oligonucleotides (For-M1-BamHI 50 TTGGATCC AGTCTTC-
TAACCGAGGTCGAA 30 and Rev-M1-EcoRI 50 TTTGAATTC
CTTGAATCGCTGCATCTGC 30) as primers. The obtained PCR product
of 770 bp was digested with BamHI and EcoRI enzymes and cloned
into a commercial vector, pGEX 2TK (GE Healthcare). The resulting
plasmid, pM1-GST was veriﬁed by restriction analysis and nucleo-
tide sequencing. pM1-GST was used to transform BL21 Escherichia
coli strain, and the recombinant strain was used to overproduce
M1-GST after addition of IPTG (ﬁnal concentration 1 mM). The
54 kDa protein was visualized in a blue-coomassie-stained gel and
puriﬁed by afﬁnity chromatography on glutathione resin (GE
Helathcare). 0.2 mg of pure M1-GST protein was obtained from
0.25 l of culture.
2.3. Production of recombinant M1 in a baculovirus expression
system
We generated a recombinant strain of Autographa californica
nuclear polyhedrosis virus (AcNPV) expressing M1 protein of
inﬂuenza virus A/England/195/2009 (H1N1), using the Bac-to-Bac
baculovirus expression system by Invitrogen (Luckow et al., 1993).
M1 sequences of inﬂuenza virus were ampliﬁed by PCR using
the pPol-M1 plasmid as the template and the following
primers: For-FB-M1-BamHI 50 TTGGATCCATGAGTCTTCTAACCGAG-
GTCGAA 30 and Rev-FB-M1-EcoRI-6xHis 50 TTGAATTCTCAGTG-
GTGGTGGTGGTGGTGCTTGAATCGCTGCATCTGC 30. The resulting
790 bp-long product was double-digested and cloned into BamHI
and EcoRI sites of the baculovirus transfer vector pFastBac1. The
recombinant baculovirus, Bac-M1, expressing M1 protein was
generated by transposition-mediated recombination. To obtain
overexpression of M1-His protein, Sf9 (Spodoptera frugiperda)
insect cells were transfected with Bac-M1 baculovirus and then
cultured for 96 h. The resulting 28 kDa M1-His protein was
visualized in a blue-coomassie stained gel and puriﬁed by afﬁnity
chromatography on Ni-NTA resin (Life Technologies).
2.4. Production of polyclonal anti-M1 antibodies
For antibody production, six C57BL/6J mice were immunized
intraperitoneally with 30 μg of puriﬁed M1-GST protein mixed
with incomplete Freund’s adjuvant in a total volume of 100 μl per
mouse. The injections took place on day 0, 14, 35, and 56. On days
24 and 45, sera samples were taken by tail bleeding. On day 66,
total blood was collected. The obtained sera was tested for puriﬁed
protein and optimal dilution of anti-M1 sera for western blot
analysis was established as 1:100,000. Universality and selectivity
of the antibodies were conﬁrmed using western blot and slot blot
methods. Anti-M1 antibodies were puriﬁed by afﬁnity chromato-
graphy on CNBr-activated Sepharose 4B coupled with M1-His
protein.
2.5. Fabrication of the immunosensor
2.5.1. Preparation of electrodes
Gold electrodes were cleaned mechanically by polishing in
a water suspension of aluminum oxide (alumina). The electrodes
were then cleaned electrochemically in a 0.5 M solution of
potassium hydroxide by using potential sweep in the range of
1200 mV to 400 mV (in relation to Ag/AgCl as the reference
electrode) at the rate of 100 mV/s, number of cycles: 3, 50, and 5.
The electrodes were then put one by one in a 0.5 M solution of
sulfuric acid and potential sweep was applied in the range of
300 mV to 1500 mV, at the rate of 100 mV/s, number of cycles:
3, 10, and 5. Finally, the surface of the electrodes was recondi-
tioned in a KOH solution by using 10 cycles.
2.5.2. Modiﬁcation of electrodes.
Clean gold electrodes were rinsed with ethanol and put in
a 10 mM solution of 1,6-hexanedithiol (HDT) in ethanol for 20 h at
room temperature (Sigma-Aldrich). The test tubes containing the
electrodes in HDT solution were sealed with a teﬂon tape and
paraﬁlm in order to avoid solvent evaporation. Next, the electrodes
were rinsed, ﬁrst with ethanol, and then with deionized water, and
turned upside down. Then, 10 μl of colloidal gold particles (GCP,
5 nm) was applied on the electrodes for 18 h at þ4 1C temperature
(Sigma-Aldrich). During the next step, the electrodes were rinsed
with 0.1 M PBS buffer pH 5.5 (145 mM NaCl, 2.7 mM KCl, 8.4 mM
NaH2PO4, and 1.6 mM Na2HPO4) and 10 μl of anti-M antibodies
solution of 28 μg/ml in 0.1 M PBS buffer was applied on the
electrodes for 2 h at þ4 1C. During the ﬁnal step, 10 μl of 0.5%
(w/v) BSA solution in 0.1 M PBS, pH 5.5, were applied on the
electrodes surface for 2 h at þ4 1C. Finally, the electrodes were
rinsed with PBS buffer and stored at þ4 1C until use.
Individual steps of the modiﬁcation were characterized using
cyclic voltammetry and impedance electrochemical spectroscopy
using ferrocyanides (Fe(CN)63 /4) as redox-active markers.
In Figs. 1 and 2 we present cyclic voltammograms and impedance
spectra obtained after consecutive modiﬁcation steps.
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2.6. Detection of M1 protein
All electrochemical measurements were performed with
a potentiostat–galvanostat AutoLab (Eco Chemie, Utrecht, Nether-
lands) with a conventional three-electrode conﬁguration with gold
electrodes unmodiﬁed or covered by different layers as working
electrodes. The prepared immunosensor was used to detect
inﬂuenza virus M protein. The virus/protein was suspended in
0.1 M PBS buffer pH 5.5 and shaken vigorously. On the surface of
the electrodes, 10 μl of solution was applied for 30 min. Next, the
electrodes were rinsed with PBS buffer and put into an electro-
chemical cell. Measurements of impedance electrochemical spec-
troscopy were performed in the presence of ferrocyanides
(Fe(CN)63/4) as redox-active markers. We observed changes in
electron transfer resistance.
2.7. Universality of the antibodies, sensitivity and selectivity
of the assay
To conﬁrm the universality of the antibodies obtained, we
performed a slot blot analysis using different inﬂuenza virus
strains (A/ostrich/Denmark/96-72420/96(H5N2), A/GraylagGoose/
Poland/MW74/10 (H5N2), A/Afri.Star./Eng-Q/938/79 (H7N1),
A/H1N1v/32u/10, A/H1N1v/47u/10). In order to make sure that
the test does not show any unspeciﬁc detection of antigens
present in the oral cavity, we tested a throat swab from a healthy
patient.
To analyze the sensitivity of the test, serial dilution of recom-
binant M1 protein in the range of 10–100 pg/ml was prepared and
measured.
3. Results
3.1. Detection of M1 protein
After preparation, the sensor was put into a buffer containing
virus particles and impedance electrochemical spectroscopy mea-
surements were performed in the presence of ferrocyanides
(Fe(CN)63/4) as redox-active markers. With increasing concen-
tration of M protein (amount of the virus) we observed an increase
in electron transfer resistance ((RiR0)/R0) (Fig. 3). Values higher
than 5% were considered as valid results. Values lower than 5%
were rejected due to a possible measuring error.
3.2. Universality of the antibodies, sensitivity, selectivity
and reproducibility of the assay
The universality of the method was conﬁrmed through a slot
blot analysis of several human and avian viruses. Speciﬁcity of the
test was assessed through analysis of a throat swab from a healthy
patient (Fig. 4).
We observed a positive reaction during analysis of all viruses,
whereas no reaction was observed during analysis of the throat
swab from a healthy patient. We conﬁrmed the speciﬁcity and
universality of the used antibodies and thus, the method itself.
Sensitivity of the method was assessed through analysis of
serial dilutions of M protein. Differences in resistance lower than
5% were rejected. This value was calculated as standard deviation
of the blank control multiplied by 5. The detection limit corre-
sponding to a difference in electron transfer resistance greater
than 5% was obtained for the concentration of 20 pg/ml (Fig. 3),
which corresponds to around 80–100 virus particles/μl. This result
is comparable to the sensitivity of molecular methods (e.g. Real-
time PCR).
The reproducibility was determined by testing a known con-
centration of M1 protein (60, 80 and 100 pg/ml) using 5 different
Fig. 1. Cyclic voltammograms recorder for consecutive steps of the immunosensor
preparation: (a) clean gold electrode; (b) 1,6-hexanedithiol; (c) GCP; (d) anti-M
antibodies; (e) BSA. Measurement conditions: 1 mM Fe(CN)63/Fe(CN)64 in 0.1 M
solution of PBS pH 5.5; scan rate 100 mV/s. GCP – gold colloidal particles.
Fig. 2. Impedance spectra recorded for consecutive steps of the immunosensor
preparation: (a) clean gold electrode; (b) 1,6-hexanedithiol; (c) GCP; (d) anti-M
antibodies; (e) BSA. Measurement conditions: 1 mM Fe(CN)63/Fe(CN)64 in 0.1 M
solution of PBS pH 5.5; scan rate 100 mV/s.; potential 0.17 V. GCP – gold colloidal
particles.
Fig. 3. Plots of the relationship between (RiR0)/R0 and C [pg/ml] – concentration
of standard M protein solutions in 0.1 M PBS pH 5.5. Ri is the value of resistance of
electron transfer through a double layer before immobilization of protein particles.
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electrodes during ﬁve days. The results show good reproducibility
because the coefﬁcient of variation was lower than 9% for each
concentration (8.9%, 7.2% and 5.2%).
4. Discussion
Development of a universal and sensitive test for quick detec-
tion of inﬂuenza virus is an important element of international
efforts to ﬁght this pathogen. Traditional diagnostic methods, like
virus propagation and isolation, antigen capture immunoassays,
and molecular methods do not meet the requirements dictated by
current diagnostic needs. The biosensors developed so far allowed
detection of viruses of selected serotypes (He et al., 2007; Li et al.,
2011; Xu et al., 2007), which restricted their applicability to
selective analyses. Other methods require sophisticated research
equipment and are often restricted to laboratory use (Hewa et al.,
2009; Li et al., 2011;Qi et al., 2010). The presented immunosensor
was developed with the intention to be used (after miniaturiza-
tion) in practice, in routine diagnostics during visits to the general
practitioner.
Due to the application of antibodies against conserved virus
antigens – anti-M1, the presented test allows detection of all
serotypes of inﬂuenza A virus. Moreover, application of polyclonal
antibodies allows a much broader spectrum of antibodies, thus
reducing the risk of false negative results (which could occur if
monoclonal antibodies were used).
Electrochemical impedance spectroscopy (EIS) is a very sensi-
tive and, at the same time, very well understood method. It is an
effective way to detect the formation of antigen–antibody on
electrode surfaces and formation of biosensors (Chang and Park,
2010; Lisdat and Schäfer, 2008). Its use for development of
biosensors has already been shown (Yang et al., 2004; Kim et al.,
2012). It guarantees simplicity of analysis. Direct attachment of
antibodies to the gold electrode is the simplest possible solution,
which reduces the need to transfer signals through proteins (e.g.
protein A) or other intermediate substances. Thus, occurrence of
noise and distortions, which can affect sensitivity and speciﬁcity of
the method, is reduced. Such solution greatly facilitates the design
process of the biosensor and also its future miniaturization.
Detection of virus antigens lasts only 30 min and does not need
isolation of the virus, genetic material, or any other complicated
procedures associated with sample preparation. A throat swab or
a saliva sample is enough to perform the analysis. The sample is
suspended in PBS buffer and shaken. The complete sample pre-
paration procedure lasts less than 1 min. The developed sensor is
characterized by high sensitivity (80–100 virions/μl), comparable
to the sensitivity of molecular methods, very high speciﬁcity, and
very short analysis time (around 30 min.).
5. Conclusions
In this study we present the universal immonosensor for the
detection of all serotypes of the inﬂuenza A virus. Using ESI and
direct immobilization it is possible to miniaturize the device down
to the size of a pen or a glucose meter strip. Application of a reader
(central unit) and exchangeable elements (for each patient) will
allow signiﬁcant reduction of the production costs of the device
and will increase its mobility, thus enabling its application in
practice.
Universality and simplicity of performing the test will not only
allow its application for diagnostics in humans, but also in animals.
The high sensitivity of the method allows for quick detection of
the virus at its early stages of infection in birds, which can greatly
contribute to taking suitable sanitary measures at early stages of
an epidemic.
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